NanoViricides, Inc. NNVC
1.44
0.00
0.00%
as of 25 Sep
- Market cap
- $38.0M
- P/E
- 0.0×
Follow NNVC
| Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | Jun '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.28 | 3.66 | 15.81 | 34.92 | 59.31 | 6.49 | 0.99 | 8.30 | 3.28 | 3.62 |
Net Debt/EBITDA |
0.18 | 0.62 | 0.99 | 1.89 | 2.55 | 1.88 | 0.32 | 0.85 | 1.47 | 2.30 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.40% | 0.31% | 0.26% | 0.00% | 0.00% | 14.65% | 23.50% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.37 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.90 | 0.76 | 0.66 | 0.73 | 0.93 | 0.50 | 0.81 | 0.91 | 0.77 | 0.64 |
Capex/Depreciation |
(0.08) | (0.21) | (0.20) | (0.45) | (0.33) | (0.01) | (0.11) | (0.23) | (0.08) | (0.23) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (99.75%) | (63.00%) | (45.27%) | (30.60%) | (34.15%) | (83.11%) | (59.62%) | (45.10%) | (47.53%) | (39.12%) | |
| (87.47%) | (55.81%) | (42.52%) | (30.16%) | (32.57%) | (71.98%) | (52.66%) | (37.60%) | (32.39%) | (26.54%) | |
ROIC |
(100.60%) | (79.84%) | (83.23%) | (55.66%) | (57.59%) | (61.61%) | (67.27%) | (55.07%) | (65.37%) | (73.88%) |
Return on Tangible Assets |
(131.52%) | (74.56%) | (53.62%) | (35.72%) | (29.85%) | (62.91%) | (82.56%) | (49.55%) | (47.06%) | (36.48%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.56) | (0.55) | (0.50) | (0.54) | (0.78) | (1.19) | (1.92) | (2.47) | (2.68) | (2.53) |
Cash per Share |
0.10 | 0.40 | 0.70 | 1.22 | 1.88 | 2.44 | 0.71 | 2.18 | 5.02 | 8.38 |
Shareholders Equity per Share |
0.50 | 0.97 | 1.28 | 2.00 | 2.74 | 3.87 | 2.95 | 5.44 | 6.76 | 7.99 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.50 | 0.97 | 1.28 | 2.00 | 2.74 | 3.87 | 2.95 | 5.44 | 6.76 | 7.99 |
Free Cash Flow |
(8.54) | (6.47) | (5.82) | (6.22) | (8.45) | (6.67) | (6.88) | (8.02) | (8.06) | (7.31) |
Working Capital |
0.36 | 3.61 | 7.91 | 14.00 | 20.47 | 11.83 | (0.02) | 6.44 | 10.62 | 17.64 |
Capital Expenditures |
(0.06) | (0.16) | (0.15) | (0.32) | (0.24) | (0.01) | (0.07) | (0.24) | (0.16) | (0.48) |
Net Current Asset Value |
0.36 | 3.61 | 6.41 | 14.00 | 20.47 | 11.83 | (0.02) | 6.44 | 8.61 | 10.80 |
| Other line items | ||||||||||
Quick Ratio |
1.19 | 3.53 | 15.25 | 34.08 | 58.44 | 6.36 | 0.90 | 8.03 | 3.24 | 3.58 |
Depreciation/Fixed assets |
0.11 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 | 0.10 | 0.18 | 0.18 |
Cash ROIC |
(168.71%) | (85.03%) | (59.86%) | (39.16%) | (34.24%) | (45.62%) | (129.45%) | (75.23%) | (48.68%) | (33.30%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.56) | (0.53) | (0.49) | (0.51) | (0.75) | (1.19) | (1.89) | (2.40) | (2.63) | (2.37) |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.03) | (0.02) | 0.00 | (0.02) | (0.07) | (0.05) | (0.17) |
Average Payables |
1.19 | 0.74 | 0.33 | 0.25 | 0.59 | 1.04 | 0.73 | 0.40 | 0.67 | 0.63 |
Average Assets |
10.82 | 14.86 | 20.20 | 26.88 | 27.09 | 18.68 | 16.00 | 22.77 | 31.82 | 40.41 |
Average Common Equity |
9.49 | 13.16 | 18.97 | 26.50 | 25.83 | 16.18 | 14.13 | 18.99 | 21.68 | 27.41 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates